In contrast to these studies,55, 56 Suzuki et al previously demonstrated that GATA‐4 activation crucially regulated pulmonary arterial smooth muscle cell proliferation, suggesting targeting at the GATA‐4 activation could be a therapeutic potential for preventing the PAH.28 This evidence concerns the gene GATA4 and pulmonary arterial hypertension.